Cited by 409RNA and protein synthesis mechanismsRNA Interference and Gene DeliveryRNA Research and Splicing

Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics

Open access
Leppek, Kathrin, Byeon, Gun Woo, Kladwang, Wipapat, Wayment-Steele, Hannah K., Kerr, Craig H., Xu, Adele F., Kim, Do Soon, Topkar, Ved V. +21 more·2022·Nature Communications

Published version of a preprint

Abstract

Therapeutic mRNAs and vaccines are being developed for a broad range of human diseases, including COVID-19. However, their optimization is hindered by mRNA instability and inefficient protein expression. Here, we describe design principles that overcome these barriers. We develop a new RNA sequencing-based platform called PERSIST-seq to systematically delineate in-cell mRNA stability, ribosome load, as well as in-solution stability of a library of diverse mRNAs. We find that, surprisingly, in-cell stability is a greater driver of protein output than high ribosome load. We further introduce a method called In-line-seq, applied to thousands of diverse RNAs, that reveals sequence and structure-based rules for mitigating hydrolytic degradation. Our findings show that "superfolder" mRNAs can be designed to improve both stability and expression that are further enhanced through pseudouridine nucleoside modification. Together, our study demonstrates simultaneous improvement of mRNA stability and protein expression and provides a computational-experimental platform for the enhancement of mRNA medicines.

AI snapshot

Written from the paper’s full text.

TL;DR

The paper develops PERSIST-seq and In-line-seq to systematically optimize therapeutic mRNA stability, structure, and translation. It finds that in-cell mRNA stability is a greater driver of total protein output than high ribosome load, and that structure-optimized CDSs plus pseudouridine modification can improve both in-solution stability and protein expression.

Key findings

  • In a 233-mRNA library, PERSIST-seq showed in-cell half-lives ranging from <5 h to >15 h; a model integrating ribosome load and in-cell stability predicted measured luciferase activity with r = 0.71, supporting in-cell stability as the dominant predictor of total protein output.
  • In-solution stability was driven mainly by mRNA length and structure: the shortest MEV-encoding mRNAs had half-lives of 3.4 ± 0.6 h, while the longest eGFP-encoding mRNAs had half-lives of 1.1 ± 0.08 h; the ratio 3.0 ± 0.7 matched the inverse length ratio 958 nt/250 nt = 3.8.
  • In-line-seq on 3,030 RNA fragments (2,165 after filtering) yielded DegScore, which predicted Nluc CDS in-solution half-lives with Pearson R = −0.63, p < 0.0001, outperforming dGMFE (R = −0.53) and summed unpaired probability (R = −0.60).
  • Pseudouridine (ψ) or m1ψ substitution suppressed in-line hydrolysis and gave 1.2–2.7-fold stabilization for longer Nluc mRNAs; a RiboTree/LinearDesign/DegScore-optimized mRNA had t1/2 = 2.4 relative to Nluc start and 1.7-fold higher protein expression, and after 2 h accelerated degradation most ψ-modified optimized mRNA remained functional while the starting mRNA gave negligible activity.

Methods

  • PERSIST-seq: pooled full-length IVT mRNA library of 233 constructs with varied 5′ UTRs, 3′ UTRs, and CDSs, barcoded and transfected into HEK293T cells; polysome sucrose-gradient fractionation and time-course sampling measured ribosome load, in-cell stability, and in-solution stability by barcode sequencing.
  • In-line-seq: Eterna “Roll-your-own-structure” challenge generated 68-nt RNAs; 3,030 fragments were profiled by single-nucleotide-resolution in-line hydrolysis and SHAPE, then DegScore was trained as a windowed ridge regression model and validated against independent PERSIST-seq in-solution half-lives.
  • Follow-up one-by-one assays used luciferase activity after transfection, capillary electrophoresis for in-solution half-lives, SHAPE/DMS chemical mapping, and ψ or m1ψ substitutions; design algorithms included LinearDesign, GC-rich codon sampling, RiboTree, and Eterna participant designs.

Limitations

  • Stated: experiments were limited to HEK293T cells, so optimal UTRs are likely cell-type dependent; the study focused on naked, non-formulated mRNAs, and formulated mRNA libraries may reveal additional effects; DegScore was trained on unmodified nucleotides and does not account for ψ stabilization; blinding and randomization were not used.
  • Evident from the text: the main pooled library contained 233 constructs, with some design rules derived from Eterna-designed subsets and accelerated degradation conditions (pH 10 with Mg2+), and the protein-output model assumes first-order translation and decay kinetics with negligible Nluc protein degradation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-022-28776-w

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

16 of 29 cited sources checked · 2 supported · 1 flagged · accuracy not yet measured

  • Interpretationcitation

    Independent of the nucleotide identity 5' of the U, the bond leading to 3' U is a hotspot for in-line nucleophilic attack.

    “Thus, independent of the nucleotide identity 5’ of the U, this bond is a hotspot for in-line nucleophilic attack63,65.”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [63] Kaukinen, U., Lyytikäinen, S., Mikkola, S. & Lönnberg, H. The reactivity of phosphodiester bonds within linear single-stranded oligoribonucleotides is strongly dependent on the base sequence. Nucleic Acids Res. 30, 468–474 (2002). source

      The Results (page unavailable) report that cleavage of the studied 5′-UpA-3′ bond varies strongly with the surrounding sequence; in one sequence, no reaction was detected in three months. The Discussion (page unavailable) explicitly rejects the idea that this bond is inherently prone to cleavage. The paper studies a bond following U, rather than establishing that a bond leading to 3′ U is a hotspot independent of the preceding nucleotide. (LLM, conf=0.82)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
    • cites [65] Seetin, M. G., Kladwang, W., Bida, J. P. & Das, R. Massively parallel RNA chemical mapping with a reduced bias MAP-seq protocol. Methods Mol. Biol. 1086, 95–117 (2014). source

      The Introduction (page unavailable) discusses chemical probing and nucleotide reactivity, and the References list a work on in-line probing. Neither passage addresses whether the bond leading to a 3′ U is a hotspot for in-line nucleophilic attack regardless of the 5′ nucleotide; searches for that mechanism and sequence preference found no supporting passage in our copy. (LLM, conf=0.73)

      Experimental — accuracy not yet measured
  • Findingown data

    Highly structured 5' UTRs, such as dengue virus (DEN2), can support efficient translation, contrary to previous reports.

    “Most surprising, in contrast to previous reports47–49, we found 5’ UTRs that are highly structured, such as the dengue virus (DEN2), can support efficient translation.”
    Quote in the paperSubstantial claim1 of 3 sources checked
    • cites [47] Zhang, H. et al. LinearDesign: efficient algorithms for optimized mRNA sequence design. Preprint at https://arxiv.org/abs/2004.10177 (2020). source

      Checked before — its earlier verdict is held back until a new check runs.

    • cites [48] Ding, Y. et al. In vivo genome-wide profiling of RNA secondary structure reveals novel regulatory features. Nature 505, 696–700 (2014). source
    • cites [49] Shah, P., Ding, Y., Niemczyk, M., Kudla, G. & Plotkin, J. B. Rate-limiting steps in yeast protein translation. Cell 153, 1589–1601 (2013). source
  • Findingown data

    PERSIST-seq data across different CDS types confirmed the effect of CDS length on RNA stability.

    “The strongest prediction of previous theoretical modeling7 was that length changes should drive the most variation in in-solution stability, and PERSIST-seq data across different different CDS types confirmed the effect of CDS length on RNA stability, (Fig. 2G).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [7] Wayment-Steele, H. K. et al. Theoretical basis for stabilizing messenger RNA through secondary structure design. Nucleic Acids Res. 49, 10604–10617 (2021). source
    • The authors state this as an assumption: The high pH buffer containing Mg2+ mimics the high effective pH and positively charged environment that can arise in lipid nanoparticles, protamine, and other formulations for mRNA therapeutics.
  • Premisecitation

    Nluc protein has negligible degradation as measured by luciferase activity in transiently Nluc-expressing HEK293 cells for at least 6 hours after cycloheximide treatment.

    “kp is set to 0 since Nluc protein has negligible degradation as measured by luciferase activity in transiently Nluc-expressing HEK293 cells for at least 6 hours after cycloheximide treatment, which allows assessment of protein degradation in the absence of further translation91.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [91] Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10 (2011). source

      The Introduction and Algorithm sections describe adapter trimming in sequencing reads, not protein degradation experiments. Searches for Nluc, HEK293, luciferase activity, and cycloheximide found no passage addressing the claimed six-hour stability. (LLM, conf=0.78)

      Experimental — accuracy not yet measured
  • Interpretationcitation

    The effect of high translation efficiency on stability may derive from overcrowding of ribosomes on mRNA coding regions due to rapid initiation, which can induce sterical ribosome collisions that lead to translation-dependent mRNA decay.

    “This effect may derive from overcrowding of ribosomes on mRNA coding regions due to rapid initiation, which can induce sterical ribosome collisions that have recently been found to lead to translation-dependent mRNA decay78,79.”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [78] Yoffe, A. M. et al. Predicting the sizes of large RNA molecules. Proc. Natl Acad. Sci. USA 105, 16153–16158 (2008). source
    • cites [79] Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020). source

      The Methods and Discussion describe BNT162b2 vaccine efficacy and safety, not how translation efficiency affects mRNA stability. Searches for ribosome collisions, rapid initiation, and translation-dependent mRNA decay found no passage addressing the claimed mechanism. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
  • May combine two claims. 22
  • Classified as probably not a substantial claim. 15
  • The quote only partly states this claim. 1
  • May combine two claims.

    Premisecitation

    mRNA vaccines still suffer from decreased efficacy due to poor RNA stability in solution and in vivo and to limited expression of the payload mRNA.

    “mRNA vaccines still suffer from decreased efficacy due to poor RNA stability in solution and in vivo and to limited expression of the payload mRNA; these are all pivotal issues that need to be carefully optimized for preclinical and clinical applications3–6.”
    Quote in the paperSubstantial claim3 of 4 sources checked
    • cites [3] Sahin, U., Karikó, K. & Türeci, Ö. mRNA-based therapeutics-developing a new class of drugs. Nat. Rev. Drug Discov. 13, 759–780 (2014). source

      The sections on improving mRNA delivery and on translation and stability describe extracellular degradation, intracellular stability, and achieving sufficient expression of the encoded protein as challenges. But Box 4 says RNA is stable in RNase-free environments, while the Conclusions say mRNA instability has been efficiently addressed. The paper therefore does not support a blanket claim that poor stability in solution and in vivo still reduces vaccine efficacy. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [4] Jackson, N. A. C., Kester, K. E., Casimiro, D., Gurunathan, S. & DeRosa, F. The promise of mRNA vaccines: a biotech and industrial perspective. npj Vaccines 5, 11 (2020). source

      The “State-of-the-art” section says mRNA is susceptible to degradation during delivery and that construct quality affects expression. “Perspective #1” links improved stability and expression to greater antigen production and potential potency. The cited paper does not specifically establish poor stability in solution as a cause of decreased vaccine efficacy. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [5] Weng, Y. et al. The challenge and prospect of mRNA therapeutics landscape. Biotechnol. Adv. 40, 107534 (2020). source
    • cites [6] Crommelin, D. J. A., Anchordoquy, T. J., Volkin, D. B., Jiskoot, W. & Mastrobattista, E. Addressing the cold reality of mRNA vaccine stability. J. Pharm. Sci. 110, 997–1001 (2021). source

      The Historical Perspective section (page unavailable) says mRNA degradation can reduce vaccine potency by slowing translation and limiting antigen expression; it also discusses degradation in solution. The Concluding Considerations section (page unavailable) links in vivo delivery and antigen production to immunogenicity, but our copy does not establish poor RNA stability in vivo as a cause of decreased vaccine efficacy. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    RNA is inherently unstable due to its 2'-hydroxyl group, and degradation of the mRNA in solution by in-line nucleophilic attack, potentially aggravated by formulations, poses a major challenge.

    “In particular, RNA is inherently unstable due its 2’-hydroxyl group, and degradation of the mRNA in solution by in-line nucleophilic attack, potentially aggravated by formulations, poses a major challenge6.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [6] Crommelin, D. J. A., Anchordoquy, T. J., Volkin, D. B., Jiskoot, W. & Mastrobattista, E. Addressing the cold reality of mRNA vaccine stability. J. Pharm. Sci. 110, 997–1001 (2021). source

      The Historical Perspective section (page not provided) describes mRNA degradation in solution, including phosphodiester-bond hydrolysis, and says cationic lipid formulations may increase cleavage rates. The Concluding Considerations section treats stability as a major formulation challenge. Our copy does not identify the 2′-hydroxyl group or in-line nucleophilic attack as the mechanism, so those specific parts are not supported. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    ψ and m1ψ substitutions for U have been widely adopted for mRNA therapeutics and vaccines due to improved in-cell translation and better control of innate immune responses.

    “In particular, we focused on ψ and m1ψ, since these substitutions for U have been widely adopted for mRNA therapeutics and vaccines due to improved in-cell translation and to better control of innate immune responses2,3,8,67 through avoidance of recognition by cellular toll-like receptors (TLR7 and TLR8)68, RIG‑I, and PKR69–71.”
    Quote in the paperSubstantial claim6 of 8 sources checked
    • cites [2] Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. mRNA vaccines - a new era in vaccinology. Nat. Rev. Drug Discov. 17, 261–279 (2018). source

      The 'Modulation of immunogenicity' section (page unavailable) says pseudouridine and 1-methylpseudouridine reduce innate immune sensing and that nucleoside-modified mRNA improves translation. It links these advances to interest in vaccines and protein-replacement therapies, but does not establish that both substitutions were widely adopted for those uses; the vaccine section describes the platform as novel. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [3] Sahin, U., Karikó, K. & Türeci, Ö. mRNA-based therapeutics-developing a new class of drugs. Nat. Rev. Drug Discov. 13, 759–780 (2014). source

      Box 1 reports that pseudouridine-modified mRNA can improve translation and reduce innate immune activation, including activation of TLR7 and TLR8. It does not identify m1ψ or establish that both substitutions were widely adopted for mRNA therapeutics and vaccines. No page number is available in our copy. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [8] Mauger, D. M. et al. mRNA structure regulates protein expression through changes in functional half-life. Proc. Natl Acad. Sci. USA 116, 24075–24083 (2019). source

      The Methods (mRNA Preparation) identify Ψ and m1Ψ as substitutions for U. The Results (RNA Sequence and Nucleotide Modifications Combine to Determine Protein Expression) report increased cell expression with m1Ψ and describe m1Ψ as having reduced immunogenicity. They do not establish improved translation for Ψ or widespread adoption of both substitutions in therapeutics and vaccines. The TLR, RIG-I, and PKR mechanism is attached to other citations in the citing sentence. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites [67] Lorenz, R. et al. ViennaRNA Package 2.0. Algorithms Mol. Biol. 6, 26 (2011). source

      The Background section discusses computational RNA folding and RNA–RNA interactions, not the use of ψ or m1ψ in mRNA therapeutics or vaccines. Searches for those substitutions, in-cell translation, and innate immune receptors found no passage addressing the attributed claim. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
    • cites [68] Diedenhofen, B. & Musch, J. cocor: a comprehensive solution for the statistical comparison of correlations. PLoS ONE 10, e0121945 (2015). source

      The Introduction and Code Examples discuss statistical tests for comparing correlations, not mRNA therapeutics or vaccines. The supplied passages do not address ψ or m1ψ substitutions, translation, or innate immune responses, so our copy provides no evidence for the attributed claim. (LLM, conf=0.78)

      Experimental — accuracy not yet measured
    • cites [69] Karikó, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833–1840 (2008). source

      The Results section reports that Ψ-containing mRNA translated more efficiently than unmodified mRNA in cultured cells, and the Discussion reports diminished immunogenicity in vivo and potential therapeutic and vaccine uses. The paper does not establish that Ψ or m1ψ had been widely adopted, and it does not report results for m1ψ. No page numbers are available in our copy. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [70] Karikó, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165–175 (2005). source
    • cites [71] Hornung, V. et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314, 994–997 (2006). source
  • May combine two claims.

    Findingown data

    Nucleotide-resolution data on thousands of small, structured model RNAs from the Eterna platform revealed novel design rules for reducing solution hydrolysis and enabled development of DegScore, a regression model for in silico RNA sequence optimization for enhanced in-solution stability.

    “Nucleotide-resolution data on thousands of small, structured model RNAs from the Eterna platform revealed novel design rules for reducing solution hydrolysis and enabled development of a regression model termed DegScore that enables in silico RNA sequence optimization for enhanced in-solution stability.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Deleting the full 5' half (dSL1-3) or the 3' half (dSL4-5) of the SARS-CoV-2 5' UTR overall increased ribosome load.

    “Deleting the full 5’ half (dSL1–3) or the 3’ half (dSL4–5) of the 5’ UTR overall increased ribosome load.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The k-mer effects included significant depletion of 5' UTRs containing out-of-frame AUG start codons relative to the main ORF and enrichments of short stem-loop motifs promoting translation.

    “These effects included significant depletion of 5’ UTRs that contain out-of-frame AUG start codons relative to the main ORF and enrichments of short stem-loop motifs promoting translation (Fig. S2F).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The dengue virus 5' and 3' UTRs both individually increase ribosome loading, and combining them into one mRNA resulted in an additive effect.

    “The dengue virus 5’ and 3’ UTRs both individually increase ribosome loading, and combining them into one mRNA resulted in an additive effect (Fig. 1E, Table S1).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The ratio of these half-lives, 3.0±0.7, matched within error the inverse ratio of the lengths of the mRNA regions captured by RT-PCR (958 nt/250 nt = 3.8), supporting theoretical predictions of length effects.

    “Indeed, the ratio of these half-lives, 3.0±0.7, matched within error the inverse ratio of the lengths of the mRNA regions captured by RT-PCR (958 nt/250 nt = 3.8), supporting theoretical predictions of length effects.”
    Quote in the paperSubstantial claim
    • The authors state this as an assumption: The high pH buffer containing Mg2+ mimics the high effective pH and positively charged environment that can arise in lipid nanoparticles, protamine, and other formulations for mRNA therapeutics.
  • May combine two claims.

    Findingown data

    Overall, a wide range of UTR-dependent translation efficiencies was observed in PERSIST-seq, which could be further fine-tuned with specific UTR sequence or CDS structure alterations.

    “Overall, we observed a wide range of UTR-dependent translation efficiencies in PERSIST-seq which could be further fine-tuned with specific UTR sequence or CDS structure alterations.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    For Nluc-encoding mRNAs, CDS variants were similar in ribosome load or showed a shift towards being less loaded with ribosomes.

    “For Nluc-encoding mRNAs, CDS variants were similar in ribosome load or showed a shift towards being less loaded with ribosomes.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    The two distinct normalization approaches gave the same results within estimated error.

    “These distinct approaches to normalizing the data gave the same results within estimated error (see below).”
    Quote in the paperNot a substantial claim
    • The authors state this as an assumption: The majority of the other RNA in the lane were degradation products from the mRNA of interest.
  • May combine two claims.

    Findingown data

    Of the DegScore coefficients, G and C were most favorable (least hydrolysis) to have 3' of the linkage, followed by A, and 3' U was most detrimental to degradation.

    “Of these coefficients, G and C were the most favorable (least hydrolysis) to have 3’ of the linkage, followed by A, and a 3’ U was most detrimental to degradation, matching our prior observations.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    The study demonstrates simultaneous improvement of mRNA stability and protein expression and provides a computational-experimental platform for the enhancement of mRNA medicines.

    “Together, our study demonstrates simultaneous improvement of mRNA stability and protein expression and provides a computational-experimental platform for the enhancement of mRNA medicines.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    "Superfolder" mRNAs can be designed to improve both stability and expression, and this improvement is further enhanced through pseudouridine nucleoside modification.

    “Our findings show that “superfolder” mRNAs can be designed to improve both stability and expression that are further enhanced through pseudouridine nucleoside modification.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Normalization of the mRNA stability data was performed using two different methods used to cross-validate.

    “Normalization was performed using two different methods used to cross-validate.”
    Quote in the paperNot a substantial claim
    • The authors state this as an assumption: The majority of the other RNA in the lane were degradation products from the mRNA of interest.
  • May combine two claims.

    Interpretationown data

    This is the first massively parallel methodology and large-scale data set applying in-line probing to RNA.

    “This is the first massively parallel methodology and large-scale data set applying in-line probing to RNA.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    Signal peptide sequences were removed from the CDS for templates and mRNA used in transfection and luciferase activity experiments because the assay relies on accumulation of luciferase in the cytosol.

    “Because this assay relies on accumulation of luciferase in the cytosol, any signal peptides sequences (Table S1) were removed from the CDS for templates and mRNA for these transfection and luciferase activity experiments.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The luciferase assay relies on accumulation of luciferase in the cytosol.
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    The count matrix was log transformed and normalized column-wise using a linear fit on the dilution series of spike-in constructs in each sample.

    “The count matrix was log transformed and normalized column-wise using a linear fit on the dilution series of spike-in constructs in each sample.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Blinding and randomization were not used in any of the experiments.

    “Blinding and randomization were not used in any of the experiments.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Amplification of the full-length cDNA product was verified on an agarose gel stained with SYBRSafe.

    “Amplification of the full-length cDNA product was verified on an agarose gel stained with SYBRSafe (Invitrogen).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    In all cases, multiple independent experiments were performed on different days to verify the reproducibility of experimental findings.

    “In all cases, multiple independent experiments were performed on different days to verify the reproducibility of experimental findings.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductown data

    Sequences were filtered for low experimental noise and to ensure that the structure predicted in ViennaRNA matched the structure inferred through SHAPE mapping data collected at the same time; these filters resulted in 2165 sequences and corresponding secondary structures.

    “For analysis of sequence and structure motifs, sequences were filtered for low experimental noise and to ensure that the structure predicted in ViennaRNA66 matched the structure inferred through SHAPE mapping data collected at the same time (see Methods); these filters resulted in 2165 sequences and corresponding secondary structures.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [66] Regulski, E. E. & Breaker, R. R. In-line probing analysis of riboswitches. Methods Mol. Biol. 419, 53–67 (2008). source
  • May combine two claims.

    Interpretationreasoning

    Our study presents advances in tackling both RNA instability and the need for mRNA to compete for translation machinery, building on two new high-throughput technologies.

    “Our study presents advances in tackling both of these challenges, building on two new high-throughput technologies.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Once delivered into patient cells, the candidate mRNA must outcompete other cytoplasmic mRNAs for the translation machinery and avoid the cellular mRNA degradation machinery to express maximum amounts of the desired encoded protein.
  • May combine two claims.

    Interpretationown data

    Structured CDS regions and a wide variety of 5' UTR elements from cellular and viral origins can sustain or even improve in-cell translation efficiency compared to reference mRNA sequences.

    “Taken together with our results above, these PERSIST-seq measurements indicate that structured CDS regions and a wide variety of 5’ UTR elements from cellular and viral origins can sustain or even improve in-cell translation efficiency compared to reference mRNA sequences.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    For applications with very short mRNAs or much longer mRNAs, the best UTRs and the sweet spot for optimal translation efficiency may be different from those identified in this study.

    “for applications with very short mRNAs (as are in use for multi-epitope cancer vaccines, and represented in our MEV sequences80) or much longer mRNAs (as are needed for antigens like the SARS-CoV-2 Spike protein), the best UTRs and the sweet spot for optimal translation efficiency may be different.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    Synthesis of mRNAs with modifications is a simple method to achieve significantly greater in-solution stability while sustaining protein expression.

    “Synthesis of mRNAs with modifications – already in wide use for mitigating innate immune response and translational shutdown by mRNA therapeutics67,68,74,75 – is therefore a simple method to achieve significantly greater in-solution stability while sustaining protein expression.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductreasoning

    DegScore was trained on degradation from unmodified nucleotides and does not account for the observed stabilization via ψ.

    “DegScore was trained on degradation from unmodified nucleotides that does not account for our observed stabilization via ψ”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    The experiments were limited to HEK293T as model human cells.

    “our experiments were limited to HEK293T as model human cells”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    The best UTRs for high protein output are likely to be cell-type dependent and will vary from application to application.

    “the best UTRs for high protein output are likely to be cell-type dependent and therefore will vary from application to application”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    These results validate and demonstrate a modular and flexible platform that is applicable to potentially any protein target of choice and can accelerate the design of overall improved mRNA therapeutics solutions.

    “These results validate and demonstrate a modular and flexible platform that is applicable to potentially any protein target of choice and can accelerate the design of overall improved mRNA therapeutics solutions.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    After purification, RNA was checked again by PAGE-Urea-TBE gel and visualized by SYBR Gold.

    “Subsequently, RNA was purified using Ampure beads + 40% polyethylene glycol 8000 (7:3) and checked again by PAGE-Urea-TBE gel and visualized by SYBR Gold.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    The integrity of each sample was checked by loading total RNA alongside a spike-in control onto a PAGE-Urea-TBE gel and visualized by SYBR Gold.

    “The integrity of each sample was checked by loading 5 μL of total RNA alongside a spike-in control (P4P62HP, 50 ng) onto a PAGE-Urea-TBE gel and visualized by SYBR Gold (Thermo Fisher).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    ψ and derivatives have been reported to stabilize mRNAs against decay in cells.

    “While ψ and derivatives have been reported to stabilize mRNAs against decay in cells67, the effects of these modifications on mRNA stability in solution have not been reported.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [67] Lorenz, R. et al. ViennaRNA Package 2.0. Algorithms Mol. Biol. 6, 26 (2011). source

      Not checked in the free run.

  • Classified as probably not a substantial claim. The quote only partly states this claim.

    Study design and conductnone given

    Each experiment was performed a minimum of three independent times.

    “Each experiment was performed a minimum of three independent times.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Non-formulated mRNAs appear optimal for certain applications including personalized cancer mRNA vaccines.

    “such non-formulated mRNAs also appear optimal for certain applications including personalized cancer mRNA vaccines81”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [81] Hu, B., Guo, H., Zhou, P. & Shi, Z.-L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 19, 141–154 (2020). source

      Checked before — its earlier verdict is held back until a new check runs.

  • May combine two claims.

    Interpretationown data

    Resistance to RNA hydrolysis, as predicted by DegScore and quantified by in-solution half-life, is important for longer protein expression, but other RNA sequence and structural features govern protein expression at shorter timescales.

    “These observations suggest that resistance to RNA hydrolysis, as predicted by DegScore and quantified by in-solution half-life, is important for longer protein expression, but that other RNA sequence and structural features govern protein expression at shorter timescales.”
    Quote in the paperSubstantial claim
36 of 36
  • The authors state this as an assumption.

    Nucleotides that are not base paired in structure are uniformly prone to hydrolytic degradation.

    “the assumption that nucleotides that are not base paired in structure would be uniformly prone to hydrolytic degradation7.”
  • The authors state this as an assumption.

    Translation follows first-order kinetics and mRNA and protein decay are exponential.

    “assuming first-order rate of translation and exponential decay for mRNAs and for proteins.”
  • The authors state this as an assumption.

    The high pH buffer containing Mg2+ mimics the high effective pH and positively charged environment that can arise in lipid nanoparticles, protamine, and other formulations for mRNA therapeutics.

    “To mimic the high effective pH and positively charged environment that can arise in lipid nanoparticles, protamine, and other formulations for mRNA therapeutics6, we used a high pH buffer containing Mg2+ to accelerate degradation (10 mM MgCl2, 50 mM Na-CHES, pH 10.0, 24 °C); conditions without Mg2+ or at lower pH lead to similar conclusions on relative stabilities across RNA variants (see below).”
  • The paper relies on this without support.

    The effects of ψ modifications on mRNA stability in solution have not been reported.

    “While ψ and derivatives have been reported to stabilize mRNAs against decay in cells67, the effects of these modifications on mRNA stability in solution have not been reported.”
  • The paper relies on this without support.

    High mRNA structure adversely impacts the cellular translational apparatus.

    “the expectation that high mRNA structure should adversely impact the cellular translational apparatus.”
  • The paper relies on this without support.

    Once delivered into patient cells, the candidate mRNA must outcompete other cytoplasmic mRNAs for the translation machinery and avoid the cellular mRNA degradation machinery to express maximum amounts of the desired encoded protein.

    “Moreover, once delivered into patient cells, the candidate mRNA must outcompete other cytoplasmic mRNAs for the translation machinery and avoid the cellular mRNA degradation machinery to express maximum amounts of the desired encoded protein.”
  • The authors state this as an assumption.

    mRNA translation and mRNA/protein decay follow first-order kinetics.

    “To calculated the expected protein levels assuming first order kinetics of mRNA translation and mRNA/protein decay, the following differential equations are used:”
  • The paper relies on this without support.

    The luciferase assay relies on accumulation of luciferase in the cytosol.

    “Because this assay relies on accumulation of luciferase in the cytosol, any signal peptides sequences (Table S1) were removed from the CDS for templates and mRNA for these transfection and luciferase activity experiments.”
  • The authors state this as an assumption.

    The majority of the other RNA in the lane were degradation products from the mRNA of interest.

    “assuming that the majority of the other RNA in the lane were degradation products from the mRNA of interest”
9 of 9

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a recent study, LinearDesign-generated sequences with three different UTRs exhibited stronger in vitro protein expression over all benchmark sequences.

    “which is also consistent with a recent study29 in which LinearDesign-generated sequences with three different UTRs exhibited stronger in vitro protein expression over all benchmark sequences”

    From Algorithm for optimized mRNA design improves stability and immunogenicity (2023) · cites this paper as [29]

    The Results section, “One-by-one tests confirm additivity of UTR, CDS, and ψ improvements” (page unavailable), reports testing a LinearDesign-1 sequence with three UTR combinations and finding twice the luciferase yield of the Nluc reference at 24 hours with hHBB UTRs. It does not support superiority across all three UTR combinations or over all benchmark sequences: expression with another UTR combination fell by 24 hours, and most of the tested combinations had lower overall activity than the reference. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • LinearDesign is likely to remain effective independent of the choice of UTRs.

    “This evidence suggests that LinearDesign is likely to remain effective independent of the choice of UTRs, which is also consistent with a recent study29 in which LinearDesign-generated sequences with three different UTRs exhibited stronger in vitro protein expression over all benchmark sequences”

    From Algorithm for optimized mRNA design improves stability and immunogenicity (2023) · cites this paper as [29]

    The Results section, “One-by-one tests confirm additivity of UTR, CDS, and ψ improvements” (page unavailable), tests LinearDesign-1 with three UTR combinations and reports twice the 24-hour luciferase yield of the Nluc reference when paired with hHBB UTRs. It does not establish effectiveness independent of UTR choice or stronger expression than all benchmarks across all three combinations; the section says most tested combinations had lower overall activity than the reference. The Discussion (page unavailable) also notes that optimal UTRs may vary by application and cell type. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • LinearDesign had a central role in their work as the starting point of their optimizations.

    “LinearDesign had a central role in their work as the starting point of their optimizations (see figure 4b of their paper), followed by fine-tunings by both human players and a Monte Carlo tree search algorithm.”

    From Algorithm for optimized mRNA design improves stability and immunogenicity (2023) · cites this paper as [29]

    The Results section (Fig. 4C; page not specified) says that both Eterna participants and RiboTree modified designs from the LinearDesign server. But the Results section (Fig. 4B; page not specified) also describes other design approaches and says RiboTree could start from random sequences, so LinearDesign was not the starting point for all the paper’s optimizations. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • LinearDesign-generated sequences showed strong stability and protein expression results with different UTRs, independently confirming our in vitro experiments.

    “LinearDesign-generated sequences showed strong stability and protein expression results with different UTRs (figures 2g and 4a of their paper), independently confirming our in vitro experiments.”

    From Algorithm for optimized mRNA design improves stability and immunogenicity (2023) · cites this paper as [29]

    The Results section reports a long in-solution half-life for LinearDesign-1 and high protein output with hHBB UTRs (Fig. 4A). It also tested different UTR combinations, but most produced lower protein output; one alternative approached hHBB expression at 6 hours but fell behind by 24 hours. Thus, strong performance across different UTRs overstates the findings. The statement about confirming the citing authors’ experiments is their own interpretation. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • They did not perform any in vivo validations.

    “However, they did not perform any in vivo validations.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Cycloheximide concentration differs by a factor of one million

    Minor

    The harvest protocol specifies 100 g/mL cycloheximide, whereas the immediately preceding treatment and the lysis buffer specify 100 μg/mL.

  • Degradation-fit equation predicts increasing intact RNA

    Minor

    The stated function approaches zero as time approaches zero and increases toward A as time passes. That contradicts the stated normalization, which makes the fraction intact equal to 1 at zero hours, and the described degradation time course.

  • RT-qPCR input RNA amounts conflict

    Minor

    The same RT-qPCR methods paragraph gives 0.5 mg and 100-200 ng as the amount of RNA converted to cDNA with iScript Supermix, without distinguishing them as separate procedures.

3 of 3

Cites

Flagged first, then by citations

2 of the 117 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Leppek, K., Byeon, G. W., Kladwang, W., Wayment-Steele, H. K., Kerr, C. H., Xu, A. F., Kim, D. S., Topkar, V. V., Choe, C., Rothschild, D., Tiu, G. C., Wellington-Oguri, R., Fujii, K., Sharma, E., Watkins, A. M., Nicol, J. J., Romano, J., Tunguz, B., Diaz, F., Cai, H., Guo, P., Wu, J., Meng, F., Shi, S., Participants, E., Dormitzer, P. R., Solórzano, A., Barna, M., & Das, R.
Affiliations
  • Stanford University (US)
  • Eterna Massive Open Laboratory (US)
  • Nvidia (United States) (US)
  • Pfizer (United States) (US)
Corresponding author
  • Barna, Maria
  • Das, Rhiju
Venue
Nature Communications
Published
2022-03-22
Volume
13
Issue
1
Pages
1536-1536
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4220991830
Cited by
399
References
117
Citations by year
2026: 88 · 2025: 127 · 2024: 99 · 2023: 53 · 2022: 23 · 2021: 8 · 2020: 1
FWCI
24.66
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by-nc)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Science Foundation
  • Damon Runyon Cancer Research Foundation (DRG-2237-15)
  • Pfizer
  • Oregon State University
  • Baidu
  • National Institutes of Health
  • University of California, San Francisco
  • Stanford Bio-X
  • Chemistry, Engineering and Medicine for Human Health, Stanford University
  • Canadian Institutes of Health Research
  • National Cancer Institute (R21CA219847)
  • National Institute of General Medical Sciences (R35GM122579)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (F30HD100123, R01HD086634)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords
mRNA stability, mRNA structure, mRNA vaccines, RNA therapeutics, protein expression, hydrolytic degradation, pseudouridine modification, mRNA design, COVID-19 vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-05.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-05.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review